Partnering with consumers is a key priority of the Commission. It is about actively working with people who use the healthcare system to ensure that care is safe, high-quality and meets people’s needs. It is embedded in health service organisations through the Partnering with Consumers Standard.
Found 886 result(s)
In March 2017, the World Health Organization (WHO) launched the third Global Patient Safety Challenge with the theme of medication without harm. In April 2020, the Commission published Australia's response, highlighting Australia's goal to reduce medication errors, adverse drug events and medication-related harm.
Delivering comprehensive care in alignment with the Comprehensive Care Standard is about ensuring that health care provided is informed by a person's clinical and personal needs and preferences, is shaped by shared decisions, and is planned and delivered in partnership with the multidisciplinary team.
Our Clinical Directors and Medical Advisors provide expert clinical advice on the wide range of programs managed by the Commission.
Clostridioides difficile infection (CDI) is a serious gastrointestinal disease, often caused by inappropriate antimicrobial use.
A central line-associated bloodstream infections (CLABSI) is a serious infection that usually requires significant treatment and a prolonged length of stay in hospital. A CLABSI can be prevented through correct insertion and line maintenance techniques, the Surveillance Implementation Guide supports these processes.
Processes for matching patients to their intended procedure, treatment or investigation are essential for ensuring that the right patient receives the right care. Most health service organisations have processes in place for patient identification and procedure matching but these may not be formally documented.